MetLife Inc. (NYSE: MET) is -20.28% lower on its value in year-to-date trading and has touched a low of $55.39 and a high of $77.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MET stock was last observed hovering at around $56.30 in the last trading session, with the day’s gains setting it 1.39% off its average median price target of $83.00 for the next 12 months. It is also 35.9% off the consensus price target high of $90.00 offered by 20 analysts, but current levels are 18.75% higher than the price target low of $71.00 for the same period.
Currently trading at $57.69, the stock is -15.42% and -17.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.59 million and changing 2.47% at the moment leaves the stock -15.08% off its SMA200. MET registered -11.68% loss for a year compared to 6-month gain of -13.13%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
The stock witnessed a -19.93% loss in the last 1 month and extending the period to 3 months gives it a -21.22%, and is -10.79% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.36% over the week and 2.79% over the month.
MetLife Inc. (MET) has around 45000 employees, a market worth around $46.31B and $69.90B in sales. Current P/E ratio is 22.69 and Fwd P/E is 6.31. Profit margin for the company is 3.40%. Distance from 52-week low is 4.15% and -25.43% from its 52-week high. The company has generated returns on investments over the last 12 months (7.80%).
MetLife Inc. (MET) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for MetLife Inc. (MET) is a “Overweight”. 20 analysts offering their recommendations for the stock have an average rating of 2.10, where 5 rate it as a Hold and 2 think it is a “Overweight”. 13 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
MetLife Inc. is expected to release its quarterly report on 05/03/2023.The EPS is expected to shrink by -62.90% this year
MetLife Inc. (MET) Top Institutional Holders
The shares outstanding are 783.70M, and float is at 659.31M with Short Float at 1.21%.
MetLife Inc. (MET) Insider Activity
A total of 40 insider transactions have happened at MetLife Inc. (MET) in the last six months, with sales accounting for 5 and purchases happening 35 times. The most recent transaction is an insider sale by PAPPAS BILL, the company’s EVP, Global Tech. & Ops. SEC filings show that PAPPAS BILL sold 2,857 shares of the company’s common stock on Mar 02 at a price of $70.96 per share for a total of $0.2 million. Following the sale, the insider now owns 48915.0 shares.
MetLife Inc. disclosed in a document filed with the SEC on Feb 27 that PAPPAS BILL (EVP, Global Tech. & Ops.) sold a total of 11,345 shares of the company’s common stock. The trade occurred on Feb 27 and was made at $71.96 per share for $0.82 million. Following the transaction, the insider now directly holds 46231.0 shares of the MET stock.
Still, SEC filings show that on Dec 20, PODLOGAR SUSAN M (EVP & Chief HR Officer) disposed off 3,000 shares at an average price of $71.91 for $0.22 million. The insider now directly holds 46,193 shares of MetLife Inc. (MET).
MetLife Inc. (MET): Who are the competitors?
The company’s main competitors (and peers) include Autoliv Inc. (ALV) that is trading 18.75% up over the past 12 months and Cigna Corporation (CI) that is 17.74% higher over the same period. Credit Suisse Group AG (CS) is -70.38% down on the 1-year trading charts.